Topic: antibiotic-resistant bacteria
RedHill Biopharma’s antibiotic cocktail RHB-105 bested an amoxicillin combination in patients with H. pylori infection, topline phase 3 data show.
Roivant has licensed a midstage drug from South Korea’s Intron Bio that it says could be transformative in the fight against resistant bacteria.
Former Bayer VP Alan Westwood has taken the reins of British antimicrobial biotech Matoke Pharma.
Recent biotech developments include improved viral delivery vehicles for gene therapy and compounds that cripple resistant bacteria.
The Chan Zuckerberg Biohub has unveiled an open-source platform for charting international infectious disease outbreaks in real time.
Insights into how bacteria hibernate and use metals to evade destruction by antibiotics could be useful in drug development.
MeMed raised $70 million for its immune system diagnostic for distinguishing between bacterial and viral infections, to reduce antibiotic misuse.
An engineered form of a naturally occurring molecule can penetrate hard-to-kill, Gram-negative bacteria.
The AstraZeneca spinout is seeking the money to fund a phase 3 trial of a drug to overcome bacterial resistance to beta-lactams.
Blueberry Therapeutics raised £10 million in series B funding that will advance a nanomedicine for athlete's foot and a fungal nail infection.